Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies?

ÖZER, NECLA

Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies?

Atıf İçin Kopyala

ÖZER N.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.44, ss.33-40, 2016 (ESCI)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 44
Basım Tarihi: 2016
Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.33-40
Hacettepe Üniversitesi Adresli: Evet

Özet

Not only atrial fibrillation is the most frequently seen arrhythmias, but also a crucial health problem due to the increased stroke and embolism risk. For patients with atrial fibrillation, the anticoagulation therapy is quite important to prevent stroke and thromboembolism. In recent years, in addition to the warfarin, new oral anticoagulants have started in our clinical practice. In this review, important works which have been done with the new anticoagulants and their reflections on our clinical practice have been tried to be summarized.